Wang, Shining
669  Ergebnisse:
Personensuche X
?
 
?
6

Correction to: A phase I, first-in-human study of TAK-164, ..:

Kim, Richard ; Leal, Alexis D. ; Parikh, Aparna...
Cancer Chemotherapy and Pharmacology.  91 (2023)  4 - p. 301-301 , 2023
 
?
 
?
8

Advances in photo-catalytic oxidation of NH3 over modified ..:

Jiang, Jiaying ; Gao, Fengyu ; Wang, Shining...
Journal of Environmental Chemical Engineering.  11 (2023)  5 - p. 110602 , 2023
 
?
10

P-203 Rationale and design of three ongoing phase 1/2 trial..:

Mian, Hira ; Touzeau, Cyrille ; Holstein, Sarah...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S147 , 2023
 
?
11

A phase I, first-in-human study of TAK-164, an antibody–dru..:

Kim, Richard ; Leal, Alexis D. ; Parikh, Aparna...
Cancer Chemotherapy and Pharmacology.  91 (2023)  4 - p. 291-300 , 2023
 
?
13

Pharmacokinetics, pharmacodynamics and safety assessment of..:

Wang, Shining ; Chen, Grace ; Merlo Pich, Emilio...
British Journal of Clinical Pharmacology.  88 (2022)  6 - p. 2899-2908 , 2022
 
?
14

Population pharmacokinetic and exposure‐response analyses f..:

Gupta, Neeraj ; Reckamp, Karen L. ; Camidge, David R....
Clinical and Translational Science.  15 (2022)  5 - p. 1143-1154 , 2022
 
?
15

Population Pharmacokinetics of Mivavotinib (TAK‐659), a Dua..:

Li, Cheryl ; Watson, Kenny ; Wang, Shining..
The Journal of Clinical Pharmacology.  63 (2022)  3 - p. 326-337 , 2022
 
1-15